Deletion mapping of chromosome region 9p21-p22 surrounding the CDKN2 locus in melanoma

International Journal of Cancer

Volumn 65, Issue 6, 1996, Pages 762-767

  Ohta, Masataka ^a,b   Berd, David ^a   Shimizu, Masayoshi ^a   Nagai, Hirokazu ^a   Cotticelli, Maria Grazia ^a   Mastrangelo, Michael ^a   Shields, Jerry A ^a   Shields, Carol L ^a   Croce, Carlo M ^a   Huebner, Kay ^a  

^a WILLS EYE HOSPITAL   (United States)

^b THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR;

ARTICLE; CHROMOSOME 9P; CHROMOSOME DELETION; CONTROLLED STUDY; GENE DELETION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SKIN MELANOMA; UVEA MELANOMA;

ALLELES; BASE SEQUENCE; CARRIER PROTEINS; CHROMOSOME MAPPING; CHROMOSOMES, ARTIFICIAL, YEAST; CHROMOSOMES, HUMAN, PAIR 9; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA, NEOPLASM; GENE DELETION; HETEROZYGOTE; HUMANS; MELANOMA; MOLECULAR SEQUENCE DATA; SKIN NEOPLASMS; UVEAL NEOPLASMS;

EID: 0029921612     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0215(19960315)65:6<762::aid-ijc9>3.0.co;2-x     Document Type: Article

References (31)

1. CAIRNS, P., MAO, L.. MERLO, A., LEE, D.J., SCHWAB, D., EBY, Y., TOKINO, K., RIET, P., BLAUGRUND, J.E. and SIDRANSKY, D., Rates of p16 (MTS1) mutations in primary tumors with 9p loss. Science, 265, 415-416 (1994).
2. CANNON-ALBRIGHT, L.A. and 15 OTHERS. Assignment of locus for familial melanoma, MLM. to chromosome 9p13-p22. Science, 258, 1148-1152 (1992).
3. CHUNG, J.Q., JHANWAR, S.C., KLEIN, W.M., BELL, D.W., LEE, W.C., ALTOMARE, D.A., NOBORI, T., OLOPADE, O.I., BUCKLER, A.J. and TESTA, J.R., p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma. Cancer Res., 54, 5547-551 (1994).
4. COLEMAN, A., FOUNTAIN, J.W., NOBORI, T., OLOPADE, O.I., ROBERTSON, G., HOUSMAN, D.E. and LUGO, T.G., Distinct deletions of chromosome 9p associated with melanoma versus glioma, lung cancer, and leukemia. Cancer Res., 54, 344-348 (1994).
5. FOUNTAIN, J.W. and 12 OTHERS, Homozygous deletions within human chromosome band 9p21 in melanoma. Proc. nat. Acad. Sci Wash., 89, 10557-10561 (1992).
6. GLANI, C. and FINOCCHIARO, G., Mutation rate of the CDKN2 gene in malignant gliomas. Cancer Res., 54, 6338-6339 (1994).
7. GOLDSTEIN, A.M., DRACOPOLI, N.C., ENGELSTEIN, M., FRASER, M.C., CLARK, W.H. and TUCKER, M., A. Linkage of cutaneous malignant melanoma/dysplastic nevi to chromosome 9p, and evidence for genetic heterogeneity. Amer. J. hum. Genet., 54, 489-496 (1994).
8. GRUIS, N.A., VELDEN, P.A., SANDKUIIJI, L.A., PRINS, D.E., WEAVERFELDHAUS, J., KAMB, A., BERGMAN, W. and FRANTS, R.R., Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds. Nature (Genet.). 10, 351-353 (1995).
9. HEALY, E., REHMAN, I., ANGUS, B. and REES, J.L., Loss of heterozygosity in sporadic primary cutaneous melanoma. Genes Chromosomes Cancer. 12, 152-156 (1995).
10. HOLLAND, E.A., BEATON, S.C., EDWARDS, B.G., KEFFORD, R.F. and MANN, G.J., Loss of heterozygosity and homozygous deletions on 9p21-22 in melanoma. Oncogene, 9, 1361-1365 (1994).
11. HUSSUSSIAN, C.J., STRUEWING, J.P., GOLDSTEIN, A.M., HIGGINS, P.A.T., ALLY, D.S., SHEAHAN, M.D., CLARK, W.H., TUCKER, M.A. and DRACOPOLI, N.C., Germline p16 mutations in familial melanoma. Nature (Genet.), 8, 15-21 (1994).
12. ICHIMURA, K., SCHMIDT, E.E., YAMAGUCHI, N., JAMES, C.D. and COLLINS, V.P, A common region of homozygous deletion in malignant human gliomas lies between the IFNalw gene cluster and the D9S171 locus. Cancer Res., 54, 3127-3130 (1994).
13. ISSHIKI, K., SENG, B.A., ELDER, D.E., GUERRY, D. and LINNENBACH, A.J., Chromosome 9 deletion in sporadic and familial melanomas in vivo. Oncogene. 9, 1649-1653 (1994).
14. JEN, J., HARPER, J.W., BIGNER, S.H., BIGNER, D.D. PAPADOPOULOS, N., MARKOWITZ, S., WILLSON, J.K.V., KINZLER, K.W. and VOGELSTEIN, B., Deletion of p16 and p15 genes in brain tumors. Cancer Res., 54, 6353-6358 (1994).
15. KAMB, A., GRUIS, N.A., WEAVER-FELDHAUS, J., LIU, Q., HARSHMAN, K., TAVTIGIAN, S.V., STOCKERT, E., DAY, R.S., JOHNSON, B.E. and SKOLNICK, M.H., A cell cycle regulator potentially involved in genesis of many tumor types. Science. 264, 436-440 (1994a).
16. KAMB, A. and 22 OTHERS, Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nature (Genet.), 8, 22-26 (1994b).
17. KWIATKOWSKI, D.J., ARMOUR, J., BALE, A.E., FOUNTAIN, J.W., GOUDIE, D., HAINES, J.L., KNOWLES, M.A., PLIZ, A., SLAUGENHUPT, S. and POVEY, S., Report on the second international workshop on human chromosome 9. Cytogenet Cell Genet., 64, 94-103 (1993).
18. MERLO, A., HERMAN, J.G., MAO, L., LEE, D.J., GABRIELSON, E., BURGER, P.C., BAYLIN, S.B. and SIDRANSKY, D., 5′CpG island methylation is associated with transcriptional silencing of the tumor suppressor pl6/CDKN2/MTS1 in human cancers. Nature (Med.), 1, 686-692 (1995).
19. NOBORI, T., MIURA, K., WU, D.J., LOIS, A., TAKABAYASHI, K. and CARSON, D.A., Deletion of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature (Lond.). 368, 753-756 (1994).
20. NANCARROW, D.J. and 12 OTHERS, Confirmation of chromosome 9p linkage in familial melanoma. Amer. J. hum. Genet., 53, 936-942 (1993).
21. OHTA, M., NAGAI, H., SHIMIZU, M., RASIO, D., BERD, D., MASTRANGELO, M., SINGH, A.D., SHIELDS, J.A., SHIELDS, C.L., CROCE, M.C. and HUEBNER, K., Rarity of somatic and germline mutations of the cyclin-dependent kinase 4 inhibitor gene, CDK4I, in melanoma. Cancer Res., 54, 5269-5272 (1994).
22. INK4 in human cancer. Proc. nat. Acad. Sci. (Wash.), 91, 11045-11049 (1994).
23. PUIO, S., RUIZ, A., LAZARO, C., CASTEL, T., LYNCH, M., PALOU, J., VILALTA, A., WEISSENBACH, J., MASCARO, J.M. and ESTIVILL, X., Chromosome 9p deletions in cutaneous malignant melanoma tumors: the minimal deleted region involves markers outside p16 (CDKN2) gene. Amer. J hum. Genet., 57, 395-402 (1995).
24. SCHMIDT, E.E., ICHIMURA, K., REIFENBERGER, G. and COLLINS, V.P., CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas. Cancer Res., 54, 6321-6324 (1994).
25. SERRANO, M., HANNON, G.J. and BEACH, D., A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature (Lond.), 366, 704-707 (1993).
26. SPEICHER, M.R., PRESCHER, G., Du MANOIR, S., JAUCH, A., HORSTHEMKE, B., BORNFELD, N., BLCHER, R. and CREMER, T., Chromosomal gains and losses in uveal melanoma detected by comparative genomic hybridization. Cancer Res., 54, 3817-3823 (1994).
27. SPRUCK, C.H., GONZALEZ-ZULUETA, M., SHIBATA, A., SIMONEAU, A.R., LIN, M.F., GONZALES, F., TSAI, Y.C. and JONES. P.A., p16 gene in uncultured tumours. Nature (Lond.), 370, 183-184 (1994).
28. WALKER, G.J., PALMER, J.M., WALTERS, M.K., NANCARROW, D.J., PARSONS, P.G. and HAYWARD, N.K., Refined localization of the melanoma (MLM) gene on chromosome 9p by analysis of allelic deletions. Oncogene. 9, 819-824 (1994).
29. WARBURTON, D., GERSEN, S., Yu. M.T., JACKSON, C., HANDELIN, B. and HOUSMAN, D., Monochromosomal rodent-human hybrids from micrpcell fusion of human lymphoblastoid cells containing an inserted dominant selectable marker. Genomics, 6, 358-366 (1990).
30. WEAVER-FELDHAUS, J., GRUIS, N.A., NEUHAUSEN, S., PASLIER, D.L., STOCKERT, E., SKOLNICK, M.H. and KAMB, A., Localization of a putative tumor suppressor gene by using homozygous deletions in melanoma. Proc. nat. Acad. Sci. (Wash.), 91, 7563-7567 (1994).
31. WU, C.L., SLOAN, P., READ, A.P., HARRIS, R.R. and THAKKER, N., Deletion mapping on the short arm of chromosome 3 in squamous cell carcinoma of the oral cavity. Cancer Res., 54, 6484-6488 (1994).